The Effect of the HEP Approach in Infants With Down Syndrome

ConditionDown Syndrome (DS)

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age4-12

SponsorIzgi Miray Demirbag

About this trial

This study evaluates the effect of the HEP (Homeostasis-Enrichment-Plasticity) approach on motor and sensory development in infants with Down syndrome. Thirty-two infants will receive either HEP or traditional therapy over 12 sessions, and outcomes will be measured using standardized developmental tests.

Eligibility criteria

Qualifiers

Must be between 4 and 12 months old

Must have been diagnosed with Down Syndrome

Must not be at any neurological risk

Parent must agree to participate regularly in the study process

Disqualifiers

History of intraventricular hemorrhage (Grade III or IV)

Major vision or hearing impairment

History of febrile convulsion

Medical conditions (e.g., oxygen dependence) that prevent active participation in the study

Trial design

Treatments tested in this trial

HEP Intervention
Traditional Therapy

Treatment groups

26 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Izgi Miray Demirbag

Lead sponsor

Medipol University

Sponsor institution

Source ClinicalTrials.gov